Trial Profile
A dose intensification trial of ONC201
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 09 Sep 2021
Price :
$35
*
At a glance
- Drugs Dordaviprone (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 30 Jul 2015 New trial record